Abstract
Although the neurohypophyseal hormones vasopressin (VP) and oxytocin (OT) are mostly known for their role respectively in antidiuresis, and in labour, lactation and maternal behavior, both might exert widespread influences either on emotion and cognition in healthy subjects, showing some gender-related differences. They interact with each other facilitating shifts between positive socially- oriented and defensive states. In fact, VP amplifies the reactivity to stressors showing also beneficial effects on attention, verbal learning as well as memory, whereas OT reduces the amplitude of the stress response, improves emotion processing, and can play a negative effect on memory and verbal learning in healthy individuals. Several data indicate the possible involvement of these neuropeptides in the pathophysiology of psychiatric conditions involving social interactions, such as autism, as well as in schizophrenia and depression. The aim of this paper is to review the literature relating to the role played by neurohypophyseal hormones in neuropsychiatric disorders. We analyzed the best of published literature dealing with the relationships between neurohypophyseal hormones and neuropsychiatric conditions like autism (AD), major depres...Continue Reading
Citations
Apr 19, 2018·International Review of Psychiatry·James Harris
Nov 30, 2018·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Bo XiangJoel Gelernter
Mar 19, 2019·The Journal of Clinical Endocrinology and Metabolism·Anna AulinasElizabeth A Lawson
Feb 2, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Michele IovinoVincenzo Triggiani
Sep 16, 2020·Neurochemical Research·Dongyang LiYu-Feng Wang
Jul 25, 2019·Journal of Clinical Medicine·Mohamed A HendausAhmed H Alhammadi
Aug 9, 2020·Frontiers in Psychology·Constança CarvalhoLuís M Vicente
Sep 7, 2018·Frontiers in Cellular Neuroscience·Yehezkel Ben-Ari
Feb 3, 2021·Aging Cell·Afsaneh MohammadnejadQihua Tan
Dec 3, 2020·International Journal of Molecular Sciences·Olivia J VeatchJason H Moore
Feb 21, 2021·Translational Psychiatry·Marion BonneauJ Kirsty Millar
Mar 14, 2020·Neuropharmacology·Agnieszka PotasiewiczAgnieszka Nikiforuk
Mar 3, 2021·International Review of Psychiatry·Bethany OakleyDeclan G Murphy
Feb 22, 2021·Neurochemical Research·Dongyang LiYu-Feng Wang
May 21, 2020·Endocrine, Metabolic & Immune Disorders Drug Targets·Michele IovinoVincenzo Triggiani